Severe bradycardia following propofol-suxamethonium sequence

Area of Science:

• Anesthesiology
• Cardiovascular Pharmacology

Background:

• Propofol is a common anesthetic agent.
• Suxamethonium is a muscle relaxant used in anesthesia.
• Bradycardia is a potential complication during anesthesia.

Purpose of the Study:

• To investigate the effect of propofol-suxamethonium sequence on heart rate.
• To evaluate the role of atropine premedication in preventing bradycardia.

Main Methods:

• Six healthy female patients undergoing laparoscopy received propofol and suxamethonium.
• Electrocardiogram (ECG) monitoring was performed.
• Patients were either unpremedicated or premedicated with atropine.

Main Results:

• Two unpremedicated patients developed severe sinus bradycardia.
• Four patients premedicated with atropine did not experience bradycardia.
• Propofol may have a vagotonic effect, unlike thiopentone.

Conclusions:

• The propofol-suxamethonium sequence can lead to severe bradycardia in unpremedicated individuals.
• Atropine premedication is effective in preventing propofol-induced bradycardia.
• Propofol might possess central vagotonic properties, potentiating suxamethonium's muscarinic effects.